CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,849,905
- in 3 filings, $12.8M under 10b5-1 plans
Net −$12,849,905. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-12 | Mazabraud Yann EVP, Head of International | Sale 10b5-1 | −14,568 | $115.43 | $1.7M | 91,182 |
| 2026-08-12 | Mazabraud Yann EVP, Head of International | Sale 10b5-1 | −18,208 | $116.49 | $2.1M | 72,974 |
| 2026-08-12 | Mazabraud Yann EVP, Head of International | Sale 10b5-1 | −17,319 | $117.47 | $2.0M | 55,655 |
| 2026-06-22 | TETRAULT LYNN A. Director | Sale 10b5-1 | −37,000 | $100.32 | $3.7M | 7,000 |
| 2026-05-15 | German Christopher Paul Corporate Controller & CAO | Sale | −4,643 | $92.21 | $428K | 0 |
| 2026-03-04 | German Christopher Paul Corporate Controller & CAO | Sale | −5,614 | $89.56 | $503K | 160 |
| 2026-02-19 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −1,308 | $100.27 | $131K | 113,589 |
| 2026-02-19 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −1,692 | $100.92 | $171K | 111,897 |
| 2026-02-19 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −800 | $102.10 | $82K | 111,097 |
| 2026-02-19 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −585 | $103.28 | $60K | 110,512 |
| 2026-02-17 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −1,200 | $99.42 | $119K | 117,266 |
| 2026-02-17 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −200 | $100.52 | $20K | 117,066 |
| 2026-02-17 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −900 | $101.70 | $92K | 116,166 |
| 2026-02-17 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −1,069 | $103.00 | $110K | 115,097 |
| 2026-02-17 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −200 | $103.84 | $21K | 114,897 |
| 2026-02-12 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −292 | $96.26 | $28K | 119,766 |
| 2026-02-12 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −400 | $97.67 | $39K | 119,366 |
| 2026-02-12 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −800 | $98.99 | $79K | 118,566 |
| 2026-02-12 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −100 | $100.10 | $10K | 118,466 |
| 2026-02-11 | Smith Hunter C Chief Financial Officer | Sale 10b5-1 | −2,266 | $98.37 | $223K | 120,558 |
Page 2 of 11 · 212 trades